![Philip Gotwals](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Gotwals
Direktör/Styrelseledamot på
CAPRICOR THERAPEUTICS, INC.
Förmögenhet: 65 999 $ per 2026-07-31
Profil
Philip J.
Gotwals is currently an Independent Director at Capricor Therapeutics, Inc. since 2023 and an Independent Director at OmniAb, Inc. starting in 2025.
Formerly, Dr. Gotwals was Vice President-Business Development & Licensing at Novartis Institutes for Biomedical Research, Inc. from 2019 to 2023, Vice President-Program Management at Altus Pharmaceuticals, Inc. from 2006 to 2009, and Senior Director-Early Development at Biogen, Inc. from 2004 to 2006.
Education includes undergraduate studies at Amherst College and a doctorate from the University of California, Berkeley.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
OMNIAB, INC. 0,02 % | 2026-06-17 | 33 333 ( 0,02 % ) | 65 999 $ | 2026-07-31 |
| 2026-02-28 | 0 ( -.--% ) | - $ | 2026-07-31 |
Aktiva positioner av Philip Gotwals
| Företag | Position | Start |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-07-21 |
| OMNIAB, INC. | Direktör/Styrelseledamot | 2025-04-18 |
Tidigare kända positioner av Philip Gotwals
| Företag | Position | Slut |
|---|---|---|
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Företagsledare/Principal | 2023-10-01 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Företagsledare/Principal | 2009-01-01 |
| BIOGEN INC. | Företagsledare/Principal | 2006-09-01 |
Redsky Partners LLC
 Redsky Partners LLC Financial ConglomeratesFinance RedSky invests long/short with a growth bias without regard to market capitalization. | Företagsledare/Principal | - |
Philip Gotwalss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
83
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Redsky Partners LLC
Redsky Partners LLC Financial ConglomeratesFinance RedSky invests long/short with a growth bias without regard to market capitalization. | Finance |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Capricor Therapeutics, Inc.
 Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
